US5985354A
(en)
*
|
1995-06-07 |
1999-11-16 |
Brown University Research Foundation |
Preparation of multiwall polymeric microcapsules from hydrophilic polymers
|
US6241982B1
(en)
|
1988-03-21 |
2001-06-05 |
Chiron Corporation |
Method for treating brain cancer with a conditionally lethal gene
|
US6569679B1
(en)
|
1988-03-21 |
2003-05-27 |
Chiron Corporation |
Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
|
US5716826A
(en)
*
|
1988-03-21 |
1998-02-10 |
Chiron Viagene, Inc. |
Recombinant retroviruses
|
US6133029A
(en)
*
|
1988-03-21 |
2000-10-17 |
Chiron Corporation |
Replication defective viral vectors for infecting human cells
|
DE69032841T2
(de)
*
|
1989-01-23 |
1999-05-12 |
Chiron Corp |
Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
|
US5328470A
(en)
†
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
US7238673B2
(en)
|
1989-03-31 |
2007-07-03 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
US5698531A
(en)
|
1989-03-31 |
1997-12-16 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
US5538722A
(en)
*
|
1989-06-13 |
1996-07-23 |
Stanford University |
Isolation, growth, differentiation and genetic engineering of human muscle cells
|
DE69031951T2
(de)
|
1989-11-16 |
1998-08-13 |
Du Pont |
Transformation von tierischen Hautzellen mit hilfe von Partikeln
|
US6090790A
(en)
|
1989-12-14 |
2000-07-18 |
Eriksson; Elof |
Gene delivery by microneedle injection
|
US5661132A
(en)
*
|
1989-12-14 |
1997-08-26 |
Auragen, Inc. |
Wound healing
|
US5697901A
(en)
*
|
1989-12-14 |
1997-12-16 |
Elof Eriksson |
Gene delivery by microneedle injection
|
US6228844B1
(en)
|
1991-11-12 |
2001-05-08 |
Vical Incorporated |
Stimulating vascular growth by administration of DNA sequences encoding VEGF
|
US6706694B1
(en)
|
1990-03-21 |
2004-03-16 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate
|
US5817491A
(en)
*
|
1990-09-21 |
1998-10-06 |
The Regents Of The University Of California |
VSV G pseusdotyped retroviral vectors
|
FR2676072B1
(fr)
*
|
1991-05-03 |
1994-11-18 |
Transgene Sa |
Vecteur de delivrance d'arn.
|
WO1993003709A1
(en)
*
|
1991-08-16 |
1993-03-04 |
Vical, Inc. |
Composition and method for treating cystic fibrosis
|
FR2681786A1
(fr)
*
|
1991-09-27 |
1993-04-02 |
Centre Nat Rech Scient |
Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
|
US6743623B2
(en)
|
1991-09-27 |
2004-06-01 |
Centre National De La Recherche Scientifique |
Viral recombinant vectors for expression in muscle cells
|
US6099831A
(en)
*
|
1992-09-25 |
2000-08-08 |
Centre National De La Recherche Scientifique |
Viral recombinant vectors for expression in muscle cells
|
AU671971B2
(en)
*
|
1991-11-29 |
1996-09-19 |
Chiron Corporation |
Anti-cancer immunotherapeutic vector constructs
|
US5693769A
(en)
*
|
1991-12-13 |
1997-12-02 |
Transcell Technologies, Inc. |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5795870A
(en)
*
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
EP0625207A1
(de)
*
|
1991-12-17 |
1994-11-23 |
The Regents Of The University Of California |
Gentherapie zur behandlung der regulatoraktivität der transmembranen leitfähigkeit bei der zytischen fibrose (cftr)
|
US6627615B1
(en)
|
1991-12-17 |
2003-09-30 |
The Regents Of The University Of California |
Methods and compositions for in vivo gene therapy
|
US5858784A
(en)
*
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
AU3597093A
(en)
|
1992-01-27 |
1993-09-01 |
Embrex Inc. |
Gene transfer in poultry by introduction of embryo cells (in ovo)
|
CA2117429A1
(en)
*
|
1992-01-27 |
1993-08-05 |
James N. Petitte |
Gene transfer in birds by introduction of dna into muscle in ovo
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
US5643578A
(en)
*
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
US5620896A
(en)
*
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
US6165993A
(en)
*
|
1992-03-23 |
2000-12-26 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US5792751A
(en)
*
|
1992-04-13 |
1998-08-11 |
Baylor College Of Medicine |
Tranformation of cells associated with fluid spaces
|
US6806084B1
(en)
|
1992-06-04 |
2004-10-19 |
The Regents Of The University Of California |
Methods for compositions for in vivo gene delivery
|
EP0646178A1
(de)
*
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
Expression kassette mit im säugetier wirt funktionnellen regulator sequenzen
|
US6936464B1
(en)
|
1992-10-02 |
2005-08-30 |
Cancer Research Technology Limited |
Immune responses to fusion proteins
|
US7001759B1
(en)
|
1993-01-26 |
2006-02-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
PT681483E
(pt)
|
1993-01-26 |
2005-11-30 |
Wyeth Corp |
Composicoes e metodos para distribuicao de material genetico
|
US5981505A
(en)
*
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
PT1473369E
(pt)
*
|
1993-01-26 |
2009-03-16 |
Wyeth Corp |
Composições e processos para a transferência de material genético
|
IL108915A0
(en)
*
|
1993-03-18 |
1994-06-24 |
Merck & Co Inc |
Polynucleotide vaccine against influenza virus
|
US5591601A
(en)
*
|
1993-05-14 |
1997-01-07 |
Ohio University Edison Animal Biotechnology Institute |
DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system
|
JPH09500013A
(ja)
|
1993-06-01 |
1997-01-07 |
ライフ・テクノロジーズ・インコーポレイテッド |
カチオン性脂質による遺伝子免疫
|
US5849719A
(en)
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
JPH09501936A
(ja)
*
|
1993-08-26 |
1997-02-25 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
生物活性ペプチドをコードする裸のポリヌクレオチドを投与するための方法、組成物および装置
|
US5679647A
(en)
*
|
1993-08-26 |
1997-10-21 |
The Regents Of The University Of California |
Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
|
US5985847A
(en)
*
|
1993-08-26 |
1999-11-16 |
The Regents Of The University Of California |
Devices for administration of naked polynucleotides which encode biologically active peptides
|
US5804566A
(en)
*
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
EP0814154B1
(de)
|
1993-09-15 |
2009-07-29 |
Novartis Vaccines and Diagnostics, Inc. |
Rekombinante Alphavirus-Vektoren
|
US6348449B1
(en)
|
1993-09-21 |
2002-02-19 |
The Trustees Of The University Of Pennsylvania |
Methods of inducing mucosal immunity
|
FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
WO1995014091A2
(en)
|
1993-11-18 |
1995-05-26 |
Chiron Viagene, Inc. |
Compositions and methods for utilizing conditionally lethal genes
|
US5674908A
(en)
|
1993-12-20 |
1997-10-07 |
Life Technologies, Inc. |
Highly packed polycationic ammonium, sulfonium and phosphonium lipids
|
ES2348013T3
(es)
*
|
1994-01-27 |
2010-11-26 |
University Of Massachusetts Medical Center |
Inmunización por inoculación de una unidad de transcripción de adn.
|
US5928944A
(en)
*
|
1994-02-04 |
1999-07-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of adenoviral-medicated cell transfection
|
US6989434B1
(en)
|
1994-02-11 |
2006-01-24 |
Invitrogen Corporation |
Reagents for intracellular delivery of macromolecules
|
US6995008B1
(en)
|
1994-03-07 |
2006-02-07 |
Merck & Co., Inc. |
Coordinate in vivo gene expression
|
GB9406498D0
(en)
*
|
1994-03-31 |
1994-05-25 |
Smithkline Beecham Biolog |
Novel compounds
|
US5739118A
(en)
*
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
EP0772689B1
(de)
|
1994-05-09 |
2007-12-19 |
Oxford Biomedica (UK) Limited |
Retrovirale vektoren mit verminderter rekombinationsrate
|
GB9409985D0
(en)
|
1994-05-18 |
1994-07-06 |
Medical Res Council |
Vaccine against mycobacterial infections
|
JPH10501136A
(ja)
|
1994-06-02 |
1998-02-03 |
カイロン コーポレイション |
ウイルスに基づく感染/トランスフェクションシステムを用いる核酸免疫化
|
IL113817A
(en)
*
|
1994-06-30 |
2001-03-19 |
Merck & Co Inc |
Polynucleotide for vaccination against the umbilical cord virus
|
US7094767B2
(en)
|
1994-07-22 |
2006-08-22 |
Merck & Co., Inc. |
Polynucleotide herpes virus vaccine
|
IL114576A0
(en)
*
|
1994-07-22 |
1995-11-27 |
Merck & Co Inc |
Polynucleotide herpes virus vaccine
|
US5837533A
(en)
*
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
US6911216B1
(en)
|
1994-10-12 |
2005-06-28 |
Genzyme Corporation |
Targeted delivery via biodegradable polymers
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
AU4740096A
(en)
*
|
1994-12-30 |
1996-07-24 |
Chiron Viagene, Inc. |
Direct administration of gene delivery vehicles at multiple sites
|
US6040295A
(en)
|
1995-01-13 |
2000-03-21 |
Genemedicine, Inc. |
Formulated nucleic acid compositions and methods of administering the same for gene therapy
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
US6605274B1
(en)
|
1995-04-11 |
2003-08-12 |
The Regents Of The University Of California |
Method for in vivo regulation of cardiac muscle contractility
|
US7422574B2
(en)
|
1995-05-19 |
2008-09-09 |
Applied Tissue Technologies, Llc |
Microseeding device for gene delivery by microneedle injection
|
US6019980A
(en)
|
1995-06-07 |
2000-02-01 |
Connaught Laboratories Limited |
Nucleic acid respiratory syncytial virus vaccines
|
US6017897A
(en)
*
|
1995-06-07 |
2000-01-25 |
Pasteur Merieux Connaught Canada |
Nucleic acid respiratory syncytial virus vaccines
|
US6083925A
(en)
*
|
1995-06-07 |
2000-07-04 |
Connaught Laboratories Limited |
Nucleic acid respiratory syncytial virus vaccines
|
US6121246A
(en)
*
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
EP0862419B2
(de)
|
1995-11-09 |
2010-11-17 |
Microbiological Research Authority |
Mikroverkapselte dna zur impfung und gentherapie
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
US5910481A
(en)
*
|
1995-11-13 |
1999-06-08 |
Immuno Ag |
Hybrid proteins with modified activity
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US6168918B1
(en)
|
1996-01-31 |
2001-01-02 |
American Home Products Corp. |
Method of detecting foreign DNA integrated in eukaryotic chromosomes
|
US5891718A
(en)
*
|
1996-03-27 |
1999-04-06 |
Vical Incorporated |
Tetracycline inducible/repressible systems
|
JP4383530B2
(ja)
|
1996-04-05 |
2009-12-16 |
ノバルティス バクシンズ アンド ダイアグノスティックス, インコーポレーテッド |
細胞巨大分子合成の阻害が減少したアルファウイルスベクター
|
CN1131314C
(zh)
*
|
1996-04-29 |
2003-12-17 |
仁文有限公司 |
含有过敏原基因的重组真核载体及其应用
|
DE69723580T2
(de)
|
1996-05-03 |
2004-06-03 |
Thomas Jefferson University |
Impfstoff gegen metastasierenden kolorektalkrebs.
|
US5851804A
(en)
*
|
1996-05-06 |
1998-12-22 |
Apollon, Inc. |
Chimeric kanamycin resistance gene
|
JP2002500502A
(ja)
|
1996-06-11 |
2002-01-08 |
メルク エンド カンパニー インコーポレーテッド |
合成c型肝炎遺伝子
|
AU3514197A
(en)
|
1996-07-03 |
1998-01-21 |
Genetics Institute Inc. |
Protease fmh-1, an ice/ced-like protease
|
JP2001501458A
(ja)
*
|
1996-08-15 |
2001-02-06 |
アメリカ合衆国 |
ヒートショックタンパク質プロモーターと局部加熱との組合せを利用した遺伝子発現の場所的及び時期的制御
|
AU740141B2
(en)
|
1996-08-23 |
2001-11-01 |
Arizona Board Of Regents On Behalf Of The University Of Arizona, The |
Neutralization-sensitive epitopes of cryptosporidium parvum
|
KR100507660B1
(ko)
|
1996-09-13 |
2005-08-10 |
리폭센 테크놀로지즈 리미티드 |
리포좀
|
US7384923B2
(en)
|
1999-05-14 |
2008-06-10 |
Lipoxen Technologies Limited |
Liposomes
|
EP0935659A1
(de)
|
1996-09-17 |
1999-08-18 |
Chiron Corporation |
Zusammensetzungen und verfahren zur behandlung intrazellulärer erkrankungen
|
US6225290B1
(en)
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
AU733719B2
(en)
|
1996-10-23 |
2001-05-24 |
Trustees Of The University Of Pennsylvania, The |
Improved vaccines
|
US6387700B1
(en)
|
1996-11-04 |
2002-05-14 |
The Reagents Of The University Of Michigan |
Cationic peptides, Cys-Trp-(LYS)n, for gene delivery
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US6204250B1
(en)
|
1996-11-22 |
2001-03-20 |
The Mount Sinai Medical Center Of The City Of New York |
Immunization of infants
|
US20020082224A1
(en)
*
|
1997-01-14 |
2002-06-27 |
Douglas J. Jolly |
Non-immunogenic prodrugs and selectable markers for use in gene therapy
|
US6034072A
(en)
*
|
1997-02-10 |
2000-03-07 |
Genemedicine, Inc. |
IL-2 gene expression and delivery systems and uses
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
AU744944B2
(en)
|
1997-03-25 |
2002-03-07 |
Morris Laster |
Bone marrow as a site for transplantation
|
US5948925A
(en)
*
|
1997-05-06 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
|
CA2301575C
(en)
|
1997-05-20 |
2003-12-23 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
US7135333B1
(en)
|
1997-08-07 |
2006-11-14 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
EP1003711B1
(de)
|
1997-08-13 |
2001-11-07 |
Biontex Laboratories GmbH |
Neue lipopolyamine, deren darstellung und anwendung
|
FR2767337B1
(fr)
|
1997-08-14 |
2002-07-05 |
Pasteur Institut |
Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
|
US6818627B1
(en)
|
1997-08-14 |
2004-11-16 |
The Trustees Of The University Of Pennsylvania |
Functional fragments of HIV-1 Vpr protein and methods of using the same
|
US7151172B1
(en)
|
1997-09-18 |
2006-12-19 |
The Trustees Of The University Of Pennsylvania |
Attenuated vif DNA immunization cassettes for genetic vaccines
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
UA78180C2
(uk)
|
1997-10-03 |
2007-03-15 |
Меріаль |
Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
|
AU745805B2
(en)
|
1997-10-28 |
2002-04-11 |
Wyeth |
Compositions and methods for delivery of genetic material
|
US6914131B1
(en)
|
1998-10-09 |
2005-07-05 |
Chiron S.R.L. |
Neisserial antigens
|
CN1263854C
(zh)
|
1997-11-06 |
2006-07-12 |
启龙股份公司 |
奈瑟球菌抗原
|
JP2001523480A
(ja)
|
1997-11-20 |
2001-11-27 |
バイカル インコーポレイテッド |
サイトカイン発現ポリヌクレオチドおよびそれらの組成物を用いた癌の処置
|
EP1032676A2
(de)
|
1997-11-28 |
2000-09-06 |
Genset |
Chlamydia trachomatis genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung
|
FR2772047B1
(fr)
|
1997-12-05 |
2004-04-09 |
Ct Nat D Etudes Veterinaires E |
Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
|
US20040062775A1
(en)
|
1997-12-05 |
2004-04-01 |
Agence Francaise De Securite Sanitaire Des Aliments |
Circovirus sequences associated with piglet weight loss disease (PWD)
|
ES2289796T3
(es)
|
1997-12-11 |
2008-02-01 |
University Of Saskatchewan |
Virus del sindrome del desmedro post-destete procedente de cerdos.
|
EP1816200B1
(de)
|
1997-12-11 |
2016-03-09 |
Merial |
Virus des multisystemischen Kümmersyndroms bei Absatzferkeln
|
AU1922999A
(en)
*
|
1997-12-16 |
1999-07-05 |
Baylor College Of Medicine |
Needle-free injection of formulated nucleic acid molecules
|
WO1999033869A2
(en)
|
1997-12-24 |
1999-07-08 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
DK1047784T4
(en)
|
1998-01-14 |
2015-06-15 |
Novartis Vaccines & Diagnostic |
NEISSERA meningitidis ANTIGENS
|
EP1792988A3
(de)
|
1998-03-18 |
2007-08-22 |
Corixa Corporation |
Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs
|
CA2323776C
(en)
|
1998-03-19 |
2010-04-27 |
Human Genome Sciences, Inc. |
Cytokine receptor common gamma chain like
|
US6395253B2
(en)
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
PT1645631E
(pt)
|
1998-05-01 |
2008-02-04 |
Novartis Vaccines & Diagnostic |
Anitigénios da neisseria meningitidis e composições
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
US6686339B1
(en)
|
1998-08-20 |
2004-02-03 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
|
EP1105490A1
(de)
|
1998-08-20 |
2001-06-13 |
Aventis Pasteur Limited |
Einschlussmembranprotein c von chlamydia kodierende nukleinsäuremoleküle
|
US6693087B1
(en)
|
1998-08-20 |
2004-02-17 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding POMP91A protein of Chlamydia
|
EP1121437B1
(de)
|
1998-10-15 |
2008-02-20 |
Novartis Vaccines and Diagnostics, Inc. |
Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
|
DK1129064T3
(da)
|
1998-11-12 |
2008-04-28 |
Invitrogen Corp |
Transfektionsreagenser
|
US7148324B1
(en)
|
1998-12-14 |
2006-12-12 |
Dendreon Corporation |
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
|
ATE519840T1
(de)
|
1998-12-16 |
2011-08-15 |
Novartis Vaccines & Diagnostic |
Menschliche cyclin-abhängige kinase (hpnqalre)
|
WO2000039303A2
(en)
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Modified hiv env polypeptides
|
CA2358385C
(en)
|
1998-12-31 |
2013-08-06 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
US7935805B1
(en)
|
1998-12-31 |
2011-05-03 |
Novartis Vaccines & Diagnostics, Inc |
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
|
JP2002533124A
(ja)
|
1998-12-31 |
2002-10-08 |
カイロン コーポレイション |
Hivポリペプチドの改善された発現およびウイルス様粒子の生成
|
US6664049B1
(en)
|
1999-01-20 |
2003-12-16 |
Aventis Pasteur S.A. |
Method and device for cell lysis
|
DK1150918T3
(da)
|
1999-02-03 |
2004-12-20 |
Biosante Pharmaceuticals Inc |
Fremgangsmåde til fremstilling af terapeutiske calciumphosphatpartikler
|
EP2357192A1
(de)
|
1999-02-26 |
2011-08-17 |
Human Genome Sciences, Inc. |
Menschliches alpha-Endokin und Verfahren zu seiner Verwendung
|
EP1721982B1
(de)
|
1999-04-15 |
2013-04-10 |
Boehringer Ingelheim Vetmedica GmbH |
Chimäre Nukleinsäuren und Polypeptide aus Iyssavirus
|
US6673601B1
(en)
|
1999-04-15 |
2004-01-06 |
Institut Pasteur |
Chimeric lyssavirus nucleic acids and polypeptides
|
NZ581940A
(en)
|
1999-04-30 |
2011-07-29 |
Novartis Vaccines & Diagnostic |
Conserved neisserial antigens
|
CA2369747A1
(en)
|
1999-04-30 |
2000-11-09 |
The Trustees Of The University Of Pennsylvania |
Mutant human cd80 and compositions for and methods of making and using the same
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6943152B1
(en)
|
1999-06-10 |
2005-09-13 |
Merial |
DNA vaccine-PCV
|
DE19928342A1
(de)
*
|
1999-06-21 |
2000-12-28 |
Deutsches Krebsforsch |
Vektoren zur gentherapeutischen Tumorbehandlung
|
US6770740B1
(en)
|
1999-07-13 |
2004-08-03 |
The Regents Of The University Of Michigan |
Crosslinked DNA condensate compositions and gene delivery methods
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
FR2796397B1
(fr)
*
|
1999-07-16 |
2006-09-01 |
Merial Sas |
Genes de calicivirus felin et vaccins notamment vaccins recombines
|
US6541458B1
(en)
|
1999-07-16 |
2003-04-01 |
Merial |
Feline calicivirus genes and vaccines in particular recombinant vaccines
|
FR2796396A1
(fr)
*
|
1999-07-16 |
2001-01-19 |
Merial Sas |
Gene de calicivirus felin et vaccin recombine les incorporant
|
US8017590B1
(en)
|
1999-10-22 |
2011-09-13 |
Sanofi Pasteur Limited |
Method of inducing and/or enhancing an immune response to tumor antigens
|
CA2864069A1
(en)
|
1999-10-29 |
2001-05-03 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigenic peptides
|
ATE446365T1
(de)
|
1999-11-18 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Menschliches fgf-21 gen und genexpressionsprodukte
|
US6241710B1
(en)
|
1999-12-20 |
2001-06-05 |
Tricardia Llc |
Hypodermic needle with weeping tip and method of use
|
EP1257298B1
(de)
|
1999-12-22 |
2008-08-06 |
The Trustees Of The University Of Pennsylvania |
Kosmid-dns-konstrukte und verfahren für deren herstellung und verwendung
|
US6656706B2
(en)
|
1999-12-23 |
2003-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
|
EP1242608A2
(de)
*
|
1999-12-28 |
2002-09-25 |
Novartis AG |
Verfahren zur erreichung einer persistierenden transgenexpression
|
AU2406901A
(en)
*
|
2000-01-07 |
2001-07-16 |
Makoto Hatakeyama |
Method for expressing gene and use thereof
|
EP2281571A3
(de)
|
2000-01-17 |
2012-04-25 |
Novartis Vaccines and Diagnostics S.r.l. |
Membranvesikel (omv) impfstoff, der n. meningitidis serogruppe b membranproteine enthält
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
RU2299906C2
(ru)
|
2000-02-28 |
2007-05-27 |
Новартис Вэксинс Энд Диагностикс С.Р.Л. |
Гетерологичная экспрессия белков neisseria
|
US7229822B1
(en)
|
2000-02-29 |
2007-06-12 |
Univ Columbia |
Melanoma differentation associated gene-5 and vectors and cells containing same
|
US6841362B1
(en)
|
2000-02-29 |
2005-01-11 |
The Trustees Of Columbia University In The City Of New York |
Melanoma differentiation associated gene-7 promoter and uses thereof
|
EP2075255A1
(de)
|
2000-03-08 |
2009-07-01 |
Novartis Vaccines and Diagnostics, Inc. |
Menschliche FGF-23-Gene und Genexpressionsprodukte
|
US6953658B2
(en)
|
2000-03-09 |
2005-10-11 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
|
EP1274861B1
(de)
|
2000-03-27 |
2009-12-23 |
Thomas Jefferson University |
Zusammensetzungen und methoden zur identifizierung von krebszellen
|
CA2405912A1
(en)
|
2000-04-12 |
2001-10-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
EP1702983A3
(de)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
|
US7238672B1
(en)
|
2000-04-17 |
2007-07-03 |
Institut Pasteur |
Chimeric lyssavirus nucleic acids and polypeptides
|
AU2001257511A1
(en)
*
|
2000-05-03 |
2001-11-12 |
Joe D'silva |
Process and device for producing liquid dosage formulations
|
EP1792995A3
(de)
|
2000-05-08 |
2007-06-13 |
Sanofi Pasteur Limited |
Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
|
EP1282702B1
(de)
|
2000-05-10 |
2006-11-29 |
Sanofi Pasteur Limited |
Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
|
EP1950297A2
(de)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung neoplastischer Erkrankungen mithilfe von Chemotherapie und Strahlungssensibilisatoren
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
US6596526B1
(en)
|
2000-06-09 |
2003-07-22 |
Baxter Aktiengesellschaft |
Furin polypeptides with improved characteristics
|
EP1734050A3
(de)
|
2000-06-12 |
2012-12-05 |
University Of Saskatchewan |
Immunisation von Milchvieh mit GapC Protein gegen Streptococcusinfektion
|
ES2398391T3
(es)
|
2000-06-15 |
2013-03-15 |
Novartis Vaccines And Diagnostics, Inc. |
Polinucleótidos relacionados con cáncer de colon
|
AU2001282856A1
(en)
|
2000-06-15 |
2001-12-24 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
US6774223B2
(en)
|
2000-06-28 |
2004-08-10 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
EP1305435B1
(de)
|
2000-07-27 |
2007-12-19 |
The Trustees Of The University Of Pennsylvania |
Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten
|
BR0113512A
(pt)
|
2000-08-25 |
2005-05-10 |
Basf Plant Science Gmbh |
Polinucleotìdeos de planta que codificam novas prenil proteases
|
AU2001292728A1
(en)
|
2000-09-18 |
2002-03-26 |
Thomas Jefferson University |
Compositions and methods for identifying and targeting stomach and esophageal cancer cells
|
EP2284183A1
(de)
|
2000-10-27 |
2011-02-16 |
Novartis Vaccines and Diagnostics S.r.l. |
Nukleinsäuren und Proteine aus den Streptokokkengruppen A und B
|
WO2002046477A2
(en)
|
2000-12-07 |
2002-06-13 |
Chiron Corporation |
Endogenous retroviruses up-regulated in prostate cancer
|
EP1363663B1
(de)
|
2001-01-12 |
2011-03-02 |
Novartis Vaccines and Diagnostics, Inc. |
Nukleinsäure mukosale immunisierung
|
WO2002064612A2
(en)
|
2001-02-09 |
2002-08-22 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor (ccr5) hdgnr10
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
AT410634B
(de)
|
2001-02-21 |
2003-06-25 |
Franz X Dr Heinz |
Attenuierte lebendimpfstoffe
|
US20040086558A1
(en)
*
|
2001-02-22 |
2004-05-06 |
Moshe Baru |
Liposome mediated dna administration
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
WO2002081642A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
AU2002303261A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
ATE470676T1
(de)
|
2001-04-13 |
2010-06-15 |
Human Genome Sciences Inc |
Anti-vegf-2 antikörper
|
EP1404713A4
(de)
|
2001-05-24 |
2004-09-22 |
Human Dna Technology Inc |
Neues keratinocyte growth factor 2 analogon in haarfollikeln
|
US8216585B2
(en)
|
2001-05-25 |
2012-07-10 |
The Trustees Of The University Of Pennsylvania |
Targeted particles and methods of using the same
|
ATE490267T1
(de)
|
2001-06-05 |
2010-12-15 |
Curevac Gmbh |
Stabilisierte mrna mit erhöhtem g/c-gehalt, kodierend für ein virales antigen
|
CA2349506C
(en)
|
2001-06-14 |
2009-12-08 |
Duke University |
A method for selective expression of therapeutic genes by hyperthermia
|
WO2003004620A2
(en)
|
2001-07-05 |
2003-01-16 |
Chiron, Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
CA2452119C
(en)
|
2001-07-05 |
2013-10-15 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
|
US10590418B2
(en)
|
2001-07-23 |
2020-03-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for RNAi mediated inhibition of gene expression in mammals
|
EP1409506B1
(de)
|
2001-07-23 |
2012-05-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Verfahren und zusammensetzungen zur rnai vermittelten inhibierung der genexpression in säugetieren
|
US6867189B2
(en)
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
ATE555798T1
(de)
|
2001-08-09 |
2012-05-15 |
Giuseppe Intini |
Gewebeimplantate und verfahren zur ihrer herstellung und verwendung
|
US7759314B2
(en)
|
2001-08-15 |
2010-07-20 |
Brown University |
Treatment of muscular dystrophies and related disorders
|
US20030170614A1
(en)
|
2001-08-31 |
2003-09-11 |
Megede Jan Zur |
Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
|
JP2005521380A
(ja)
|
2001-08-31 |
2005-07-21 |
カイロン コーポレイション |
抗原性b型hivポリペプチドをコードするポリヌクレオチド、そのポリペプチドおよびそれらの使用
|
WO2003029429A2
(en)
|
2001-10-03 |
2003-04-10 |
Selective Genetics, Inc. |
Traversal of nucleic acid molecules through a fluid space and expression in repair cells
|
US7498407B2
(en)
|
2001-11-09 |
2009-03-03 |
Georgetown University |
Vascular endothelial cell growth inhibitor, VEGI-192a
|
EP2335724A1
(de)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisierung gegen Chlamydia trachomatis
|
DE10162480A1
(de)
*
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
ES2545090T3
(es)
|
2001-12-21 |
2015-09-08 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina y GCSF
|
DE60326931D1
(de)
|
2002-01-08 |
2009-05-14 |
Novartis Vaccines & Diagnostic |
In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
|
AU2003235707A1
(en)
*
|
2002-01-18 |
2003-07-30 |
Curevac Gmbh |
Immunogenic preparations and vaccines on the basis of mrna
|
FR2845918A1
(fr)
*
|
2002-10-16 |
2004-04-23 |
Pasteur Institut |
Preparations immunogenes et vaccinantes a base d'arn
|
CA2479730A1
(en)
|
2002-03-21 |
2003-10-02 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
EP1356820A1
(de)
|
2002-04-26 |
2003-10-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
DNA-Impfstoff kombiniert mit einen Apoptoneauslöser von Tumorzellen
|
US20030206916A1
(en)
|
2002-05-03 |
2003-11-06 |
Rush-Presbyterian-St. Luke's Medical Center |
Immunogenic peptides
|
AU2003276679A1
(en)
|
2002-06-13 |
2003-12-31 |
Chiron Corporation |
Vectors for expression of hml-2 polypeptides
|
IL166612A0
(en)
|
2002-08-29 |
2006-01-15 |
Univ Leland Stanford Junior |
Circular nucleic acid vectors and methods for making and using the same
|
US7135324B2
(en)
|
2002-09-04 |
2006-11-14 |
The University Of Connecticut |
Viral recombinases, related articles, and methods of use thereof
|
UA80447C2
(en)
|
2002-10-08 |
2007-09-25 |
|
Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
|
EP1562982B1
(de)
|
2002-11-15 |
2010-05-05 |
Novartis Vaccines and Diagnostics S.r.l. |
Unerwartete oberflächenproteine in neisseria meningitidis
|
EP1903056A3
(de)
|
2002-12-10 |
2008-05-07 |
Idm Pharma, Inc. |
HLA-A1, -A2, -A3, -A24, -B7 and -B44 bindende Peptide die Tumorassoziiert-Antigen Epitopen enthalten, und Zusammensetzungen davon
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
CA2511598C
(en)
|
2002-12-24 |
2016-09-13 |
Rinat Neuroscience Corp. |
Anti-ngf antibodies and methods using same
|
JP2007524362A
(ja)
|
2003-02-14 |
2007-08-30 |
サイグレス ディスカバリー, インコーポレイテッド |
癌における治療gpcr標的
|
US7767387B2
(en)
|
2003-06-13 |
2010-08-03 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
US20040170982A1
(en)
|
2003-02-14 |
2004-09-02 |
Morris David W. |
Novel therapeutic targets in cancer
|
CA2516454A1
(en)
|
2003-02-19 |
2004-09-02 |
Rinat Neuroscience Corp. |
Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
WO2005007673A2
(en)
|
2003-07-03 |
2005-01-27 |
Rush University Medical Center |
Immunogenic peptides
|
JP5030594B2
(ja)
|
2003-12-23 |
2012-09-19 |
アルボー ビータ コーポレーション |
Hpvの発癌性株に対する抗体およびそれらの使用方法
|
EP1700121A4
(de)
|
2003-12-23 |
2008-09-03 |
Rinat Neuroscience Corp |
Agonistische anti-trkc-antikörper und verfahren zur verwendung davon
|
CA2555921A1
(en)
|
2004-02-13 |
2005-09-15 |
Nod Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of making and using same
|
DK1736541T3
(da)
|
2004-03-29 |
2013-05-06 |
Galpharma Co Ltd |
Nyt modificeret galectin 9-protein og anvendelse heraf
|
ES2338344T3
(es)
|
2004-04-07 |
2010-05-06 |
Rinat Neuroscience Corporation |
Procedimiento de tratamiento del dolor de cancer de hueso mediante la administracion de una antagonista del factor de crecimiento neuronal.
|
PL1747023T5
(pl)
|
2004-05-04 |
2017-05-31 |
Univ Leland Stanford Junior |
Sposób i kompozycje do zmniejszania ilości genomu wirusowego HCV w komórkach docelowych
|
EP1598428A1
(de)
|
2004-05-18 |
2005-11-23 |
Georg Dewald |
Verfahren und Kits zum Nachweis von erblichen angioedema typ III
|
WO2006014422A2
(en)
|
2004-07-06 |
2006-02-09 |
The Trustees Of Columbia University In The City Of New York |
Polynucleotide encoding a trim-cyp polypeptide, compositions thereof, and methods of using same
|
EP2495252B1
(de)
|
2004-07-09 |
2018-04-18 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
Lösliche Formen von Hendra- und Nipah-Virus-G-Glycoprotein
|
US20060024677A1
(en)
|
2004-07-20 |
2006-02-02 |
Morris David W |
Novel therapeutic targets in cancer
|
US7927594B2
(en)
|
2004-07-30 |
2011-04-19 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide
|
WO2006135382A2
(en)
|
2004-08-04 |
2006-12-21 |
Chemocentryx, Inc. |
Enzymatic activities in chemokine-mediated inflammation
|
WO2006050394A2
(en)
|
2004-11-01 |
2006-05-11 |
Novartis Vaccines And Diagnostics Inc. |
Combination approaches for generating immune responses
|
CA2586035A1
(en)
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
BRPI0518662B1
(pt)
|
2004-11-30 |
2020-12-22 |
Merial, Inc. |
processo e aparelho para lise de compostos biológicos
|
US7939490B2
(en)
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
US7803910B2
(en)
|
2005-01-24 |
2010-09-28 |
Merck Serono S.A. |
Soluble CD164 polypeptides
|
NZ580974A
(en)
|
2005-02-18 |
2011-05-27 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic escherichia coli
|
EP1871911A2
(de)
|
2005-04-07 |
2008-01-02 |
Chiron Corporation |
Gene in verbindung mit krebs (prlr)
|
US20090214536A1
(en)
|
2005-04-07 |
2009-08-27 |
Guoying Yu |
CACNA1E in Cancer Diagnosis, Detection and Treatment
|
US9119901B2
(en)
|
2005-04-28 |
2015-09-01 |
Warsaw Orthopedic, Inc. |
Surface treatments for promoting selective tissue attachment to medical impants
|
CN101282994B
(zh)
|
2005-07-22 |
2013-09-18 |
Y's治疗有限公司 |
抗cd26抗体及其使用方法
|
CN101355960A
(zh)
|
2005-10-18 |
2009-01-28 |
诺华疫苗和诊断公司 |
使用α病毒复制子颗粒进行粘膜和全身免疫
|
PT2380592T
(pt)
|
2005-11-14 |
2018-06-06 |
Teva Pharmaceuticals Int Gmbh |
Anticorpos antagonistas dirigidos contra o péptido relacionado com o gene da calcitonina e métodos utilizando os mesmos
|
CA2630220C
(en)
|
2005-11-22 |
2020-10-13 |
Doris Coit |
Norovirus and sapovirus antigens
|
US8026354B2
(en)
|
2005-11-23 |
2011-09-27 |
Institut Pasteur |
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
|
EP1803814A1
(de)
|
2005-12-27 |
2007-07-04 |
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. |
Methode zur Verbesserung der Antikörperselektionskapazität in einer Phagen-Display-Bibliothek
|
GB0606190D0
(en)
|
2006-03-28 |
2006-05-10 |
Isis Innovation |
Construct
|
TWI429658B
(zh)
|
2006-06-07 |
2014-03-11 |
Bioalliance Cv |
辨認癌症細胞上表現的cd43與cea之含碳水化合物抗原決定區的抗體及其使用方法
|
EP2035035A2
(de)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogene zusammensetzungen für streptococcus agalactiae
|
US8323815B2
(en)
|
2006-06-16 |
2012-12-04 |
Porous Power Technology, LLC |
Optimized microporous structure of electrochemical cells
|
CA2655990A1
(en)
|
2006-06-22 |
2007-12-27 |
Tai June Yoo |
Restoration of hearing loss
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
EP2586790A3
(de)
|
2006-08-16 |
2013-08-14 |
Novartis AG |
Immunogene von uropathogenen Escherichia coli
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
NZ579050A
(en)
|
2007-02-06 |
2012-10-26 |
Tai June Yoo |
Treatment and prevention of neurodegenerative diseases using gene therapy
|
US8673859B2
(en)
|
2007-03-20 |
2014-03-18 |
New York University |
GM-CSF cosmeceutical compositions and methods of use thereof
|
US20100261640A1
(en)
|
2007-04-10 |
2010-10-14 |
Branco Luis M |
Soluble and membrane anchored forms of lassa virus subunit proteins
|
KR101625363B1
(ko)
|
2007-05-10 |
2016-05-30 |
애질런트 테크놀로지스, 인크. |
Rna 합성을 위한 티오카본-보호기
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US7855049B2
(en)
|
2007-08-31 |
2010-12-21 |
Biocrine Ab |
Inositol pyrophosphates determine exocytotic capacity
|
US9593340B2
(en)
|
2007-10-15 |
2017-03-14 |
Admedus Vaccines Pty Ltd. |
Expression system for modulating an immune response
|
US8591898B2
(en)
|
2007-12-17 |
2013-11-26 |
Pfizer Limited |
Treatment of interstitial cystitis
|
CN101918448A
(zh)
|
2007-12-18 |
2010-12-15 |
生物联合公司 |
识别癌细胞上表达的cd-43和cea的含糖表位的抗体及其使用方法
|
WO2009111088A2
(en)
*
|
2008-01-02 |
2009-09-11 |
The Johns Hopkins University |
Antitumor immunization by liposomal delivery of vaccine to the spleen
|
AU2009234389B2
(en)
|
2008-04-10 |
2014-08-21 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR mutations in cancer
|
JP5546107B2
(ja)
*
|
2008-04-17 |
2014-07-09 |
国立大学法人宇都宮大学 |
RNAウイルスBmMLV陰性カイコ培養細胞株
|
EP2315833B8
(de)
|
2008-05-20 |
2015-05-27 |
Eos Neuroscience, Inc. |
Vektoren zur freisetzung lichtempfindlicher proteine und anwendungsverfahren dafür
|
WO2009150623A1
(en)
|
2008-06-13 |
2009-12-17 |
Pfizer Inc |
Treatment of chronic prostatitis
|
CA2736799A1
(en)
|
2008-08-25 |
2010-03-11 |
Burnham Institute For Medical Research |
Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
|
US20130324478A1
(en)
|
2008-09-08 |
2013-12-05 |
Laurence Faure |
Pharmacodiagnosis Test Targeting Oncology and Neurodegeneration
|
TWI445716B
(zh)
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Pcsk9拮抗劑類
|
CA2738019A1
(en)
|
2008-09-23 |
2010-04-08 |
President And Fellows Of Harvard College |
Sirt4 and uses thereof
|
US8835617B2
(en)
|
2008-11-06 |
2014-09-16 |
The Trustees Of Columbia University In The City Of New York |
Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
WO2010086828A2
(en)
|
2009-02-02 |
2010-08-05 |
Rinat Neuroscience Corporation |
Agonist anti-trkb monoclonal antibodies
|
JP2012519482A
(ja)
|
2009-03-06 |
2012-08-30 |
ノバルティス アーゲー |
クラミジア抗原
|
ES2548987T3
(es)
|
2009-03-27 |
2015-10-22 |
Christine Chomienne |
Ácido nucleico antisentido de kanamicina para el tratamiento del cáncer
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
DK2510947T3
(en)
|
2009-04-14 |
2016-03-21 |
Glaxosmithkline Biolog Sa |
Compositions for Immunization against Staphylococcus aureus.
|
WO2010135573A2
(en)
|
2009-05-20 |
2010-11-25 |
Porous Power Technologies, Llc |
Treatment and adhesive for microporous membranes
|
WO2010146511A1
(en)
|
2009-06-17 |
2010-12-23 |
Pfizer Limited |
Treatment of overactive bladder
|
FR2947455B1
(fr)
|
2009-07-01 |
2014-01-03 |
Centre Nat Rech Scient |
La dermaseptine b2 comme inhibiteur de la croissance tumorale
|
EP2451833B1
(de)
|
2009-07-07 |
2018-01-17 |
GlaxoSmithKline Biologicals SA |
Konservierte escherichia-coli-immunogene
|
DK2464658T3
(en)
|
2009-07-16 |
2014-12-15 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
TWI627281B
(zh)
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
GB0918679D0
(en)
|
2009-10-23 |
2009-12-09 |
Iqur Ltd |
Influenza vaccine
|
GB0918782D0
(en)
|
2009-10-26 |
2009-12-09 |
St Georges Hosp Medical School |
A protein as an adjuvant for a vaccine
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
AU2016250459B2
(en)
*
|
2009-12-01 |
2018-06-28 |
Translate Bio, Inc. |
Delivery Of mRNA For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases
|
NZ600616A
(en)
*
|
2009-12-01 |
2014-11-28 |
Shire Human Genetic Therapies |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
AU2014250713B2
(en)
*
|
2009-12-01 |
2016-07-28 |
Translate Bio, Inc. |
Delivery Of mRNA For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases
|
AR080291A1
(es)
|
2010-02-24 |
2012-03-28 |
Rinat Neuroscience Corp |
Anticuerpos antagonistas anti receptor de il-7 y procedimientos
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
KR20120138241A
(ko)
|
2010-03-11 |
2012-12-24 |
화이자 인코포레이티드 |
pH 의존성 항원 결합을 갖는 항체
|
GB201004475D0
(en)
|
2010-03-17 |
2010-05-05 |
Isis Innovation |
Gene silencing
|
US9247720B2
(en)
|
2010-03-24 |
2016-02-02 |
Institut National de la Santé et de la Recherche Médicale |
Primate model from the family cercopithecidae infected by a HBV strain of human genotype
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
EP2383286A1
(de)
|
2010-04-30 |
2011-11-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und Zusammensetzungen zur Behandlung von degenerativen Netzhauterkrankungen
|
EP2576613A1
(de)
|
2010-06-07 |
2013-04-10 |
Pfizer Inc. |
Her-2-peptide und impfstoffe
|
US20130122033A1
(en)
|
2010-07-02 |
2013-05-16 |
Rita De Santis |
Fimh vaccine against urinary tract infections (uti)
|
JP5940064B2
(ja)
|
2010-07-06 |
2016-06-29 |
ノバルティス アーゲー |
低用量のrnaを用いた大型哺乳動物の免疫化
|
LT3243526T
(lt)
|
2010-07-06 |
2020-02-10 |
Glaxosmithkline Biologicals S.A. |
Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
|
BR112013000244A2
(pt)
|
2010-07-06 |
2016-05-17 |
Novartis Ag |
lipossomas com lipídeos apresentando pka vantajoso para administração de rna
|
US8747844B2
(en)
|
2010-07-30 |
2014-06-10 |
Saint Louis University |
Methods of treating pain
|
EP3578205A1
(de)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
|
GB201014026D0
(en)
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
EP4066819B1
(de)
|
2010-08-31 |
2023-03-01 |
GlaxoSmithKline Biologicals SA |
Kleine liposomen zur freisetzung von ein immunogen kodierender rns
|
SI2611461T1
(sl)
|
2010-08-31 |
2022-08-31 |
Glaxosmithkline Biologicals Sa |
Pegilirani liposomi za dostavo imunogen-kodirajoče RNA
|
CA2813466A1
(en)
|
2010-10-01 |
2012-04-05 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids that disrupt major groove binding partner interactions
|
AU2011316707A1
(en)
|
2010-10-11 |
2013-05-09 |
Novartis Ag |
Antigen delivery platforms
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
US9539427B2
(en)
|
2010-11-08 |
2017-01-10 |
The Johns Hopkins University |
Methods for improving heart function
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
WO2012092299A1
(en)
|
2010-12-27 |
2012-07-05 |
Brown University |
Therapeutic and diagnostic methods involving biglycan and utrophin
|
FR2972006B1
(fr)
|
2011-02-24 |
2016-03-25 |
Centre Nat Rech Scient |
Nouveaux fragments d'il-33 superactifs et leurs utilisations
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
US9540610B2
(en)
|
2011-04-28 |
2017-01-10 |
Warsaw Orthopedic, Inc. |
Collagen and cell implant
|
EP4043025A1
(de)
|
2011-06-08 |
2022-08-17 |
Translate Bio, Inc. |
Lipidnanoteilchenzusammensetzungen und verfahren zur mrna-freisetzung
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
US20130071375A1
(en)
|
2011-08-22 |
2013-03-21 |
Saint Louis University |
Compositions and methods for treating inflammation
|
WO2013028527A1
(en)
|
2011-08-23 |
2013-02-28 |
Indiana University Research And Technology Corporation |
Compositions and methods for treating cancer
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
CN110511939A
(zh)
|
2011-10-03 |
2019-11-29 |
现代泰克斯公司 |
修饰的核苷、核苷酸和核酸及其用途
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
BR112014011331A2
(pt)
|
2011-11-11 |
2017-04-25 |
Rinat Neuroscience Corp |
anticorpos específicos para trop-2 e seus usos
|
EP2791160B1
(de)
|
2011-12-16 |
2022-03-02 |
ModernaTX, Inc. |
Modifizierte mrna zusammensetzungen
|
EP2794659A1
(de)
|
2011-12-22 |
2014-10-29 |
Rinat Neuroscience Corp. |
Antikörper gegen den menschlichen wachstumshormon-rezeptorantagonisten und verwendungsverfahren dafür
|
WO2013093693A1
(en)
|
2011-12-22 |
2013-06-27 |
Rinat Neuroscience Corp. |
Staphylococcus aureus specific antibodies and uses thereof
|
US20150038557A1
(en)
|
2012-02-24 |
2015-02-05 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treatment of retinal degenerative diseases
|
CN104271772A
(zh)
|
2012-03-29 |
2015-01-07 |
科罗拉多州立大学董事会,公司实体 |
点击核酸
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
EP2833923A4
(de)
|
2012-04-02 |
2016-02-24 |
Moderna Therapeutics Inc |
Modifizierte polynukleotide zur herstellung von proteinen
|
MX359257B
(es)
|
2012-05-04 |
2018-09-19 |
Pfizer |
Antígenos asociados a próstata y regímenes de inmunoterapia basados en vacuna.
|
US20150267192A1
(en)
|
2012-06-08 |
2015-09-24 |
Shire Human Genetic Therapies, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
CN104519915A
(zh)
|
2012-06-08 |
2015-04-15 |
夏尔人类遗传性治疗公司 |
肺部递送mRNA至非肺靶细胞
|
AU2013286866B2
(en)
|
2012-07-02 |
2018-03-01 |
Commonwealth Scientific And Industrial Research Organization |
Paramyxovirus and methods of use
|
US8603470B1
(en)
|
2012-08-07 |
2013-12-10 |
National Cheng Kung University |
Use of IL-20 antagonists for treating liver diseases
|
US20150268248A1
(en)
*
|
2012-09-06 |
2015-09-24 |
Memorial Sloan-Kettering Cancer Center |
Cell selective proteome labeling
|
BR112015010722A2
(pt)
|
2012-11-09 |
2017-08-22 |
Pfizer |
Anticorpos específicos de fator de crescimento derivado de plaquetas de isoforma b e composições e usos dos mesmos
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
WO2014120975A1
(en)
|
2013-02-01 |
2014-08-07 |
California Institute Of Technology |
Antibody-mediated immunocontraception
|
EP2958586B1
(de)
|
2013-02-21 |
2018-09-05 |
Boehringer Ingelheim Vetmedica GmbH |
H5-proteine aus dem h5n1-influenzavirus zur verwendung als arzneimittel
|
PE20151773A1
(es)
|
2013-03-14 |
2015-12-20 |
Shire Human Genetic Therapies |
COMPOSICIONES DE ARNm DE CFTR, METODOS Y USOS RELACIONADOS
|
AU2014240045A1
(en)
|
2013-03-15 |
2015-09-10 |
Dyax Corp. |
Anti-plasma kallikrein antibodies
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
SG11201508264UA
(en)
|
2013-05-07 |
2015-11-27 |
Rinat Neuroscience Corp |
Anti-glucagon receptor antibodies and methods of use thereof
|
JP2016528176A
(ja)
|
2013-06-06 |
2016-09-15 |
ジェイ ローランズ、デビッド |
シングルドメイン抗体ディスプレイ
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
MX371455B
(es)
|
2013-08-02 |
2020-01-28 |
Pfizer |
Anticuerpos anti-cxcr4 y conjugados de anticuerpo y farmaco.
|
KR102319843B1
(ko)
|
2013-09-25 |
2021-10-29 |
조에티스 서비시즈 엘엘씨 |
Pcv2b 분지형 백신 조성물 및 사용 방법
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
SG11201602503TA
(en)
|
2013-10-03 |
2016-04-28 |
Moderna Therapeutics Inc |
Polynucleotides encoding low density lipoprotein receptor
|
EP4276176A3
(de)
|
2013-10-22 |
2024-01-10 |
Translate Bio, Inc. |
Mrna-therapie für argininosuccinat-synthase-mangel
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
KR102366076B1
(ko)
|
2013-11-13 |
2022-02-21 |
화이자 인코포레이티드 |
종양 괴사 인자-유사 리간드 1a 특이적 항체 및 그의 조성물 및 용도
|
WO2015087187A1
(en)
|
2013-12-10 |
2015-06-18 |
Rinat Neuroscience Corp. |
Anti-sclerostin antibodies
|
WO2015092710A1
(en)
|
2013-12-19 |
2015-06-25 |
Glaxosmithkline Biologicals, S.A. |
Contralateral co-administration of vaccines
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
US9896502B2
(en)
|
2014-03-21 |
2018-02-20 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
US9950061B2
(en)
|
2014-04-03 |
2018-04-24 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine epidemic diarrhea virus vaccine
|
EP3981437A1
(de)
|
2014-04-23 |
2022-04-13 |
ModernaTX, Inc. |
Nukleinsäureimpfstoffe
|
EP3134546A4
(de)
|
2014-04-24 |
2017-12-06 |
Dana-Farber Cancer Institute, Inc. |
Tumorsuppressor und onkogene biomarker zur vorhersage der anti-immun-checkpoint-inhibitorreaktion
|
WO2015168474A1
(en)
|
2014-04-30 |
2015-11-05 |
President And Fellows Of Harvard College |
Fusion proteins for treating cancer and related methods
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
CN106572974B
(zh)
|
2014-07-15 |
2021-04-23 |
生命技术公司 |
用于将分子有效递送到细胞的具有脂质聚集体的组合物和方法
|
CA2963091A1
(en)
|
2014-10-06 |
2016-04-14 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
CN113230384A
(zh)
|
2014-10-09 |
2021-08-10 |
丹娜法伯癌症研究院 |
用于治疗免疫失调的多次-可变il-2剂量方案
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗pd-1抗體類和使用彼等之方法
|
CA2977532A1
(en)
|
2015-03-06 |
2016-09-15 |
Dana-Farber Cancer Institute, Inc. |
Pd-l2 biomarkers predictive of pd-1 pathway inhibitor responses in esophagogastric cancers
|
US9758575B2
(en)
|
2015-04-06 |
2017-09-12 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
|
BR112017019785B1
(pt)
|
2015-04-13 |
2022-11-16 |
Pfizer Inc |
Anticorpo biespecífico, seu uso e composição farmacêutica
|
AU362290S
(en)
|
2015-05-08 |
2015-06-15 |
|
Extrusion
|
AU362291S
(en)
|
2015-05-08 |
2015-06-15 |
|
Extrusion
|
WO2017004022A2
(en)
|
2015-06-29 |
2017-01-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Degron fusion constructs and methods for controlling protein production
|
WO2017015334A1
(en)
|
2015-07-21 |
2017-01-26 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
TW201718638A
(zh)
|
2015-07-21 |
2017-06-01 |
現代治療公司 |
傳染病疫苗
|
BR112018001202A2
(pt)
|
2015-07-21 |
2018-09-25 |
Dyax Corp |
anticorpo monoclonal, ácido nucleico, vetor, célula hospedeira, composição farmacêutica e método
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
WO2017015619A1
(en)
|
2015-07-23 |
2017-01-26 |
The Regents Of The University Of California |
Antibodies to coagulation factor xia and uses thereof
|
MY195443A
(en)
|
2015-08-19 |
2023-01-21 |
Pfizer |
Tissue Factor Pathway Inhibitor Antibodies and uses Thereof
|
ES2778649T3
(es)
|
2015-08-31 |
2020-08-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacunas pestivirales para temblores congénitos
|
PT3350220T
(pt)
|
2015-09-15 |
2021-08-06 |
Scholar Rock Inc |
Anticorpos anti-pró-miostatina/miostatina latente e suas utilizações
|
MX2018003173A
(es)
|
2015-09-16 |
2018-05-17 |
Boehringer Ingelheim Vetmedica Inc |
Vacunas de salmonella choleraesuis-salmonella typhimurium.
|
PT3350157T
(pt)
|
2015-09-17 |
2022-03-18 |
Modernatx Inc |
Compostos e composições para administração intracelular de agentes terapêuticos
|
WO2017066561A2
(en)
|
2015-10-16 |
2017-04-20 |
President And Fellows Of Harvard College |
Regulatory t cell pd-1 modulation for regulating t cell effector immune responses
|
EP4349404A2
(de)
|
2015-10-22 |
2024-04-10 |
ModernaTX, Inc. |
Impfstoffe gegen respiratorische viren
|
MA45209A
(fr)
|
2015-10-22 |
2019-04-17 |
Modernatx Inc |
Vaccins contre les maladies sexuellement transmissibles
|
CN117731769A
(zh)
|
2015-10-22 |
2024-03-22 |
摩登纳特斯有限公司 |
用于水痘带状疱疹病毒(vzv)的核酸疫苗
|
JP6921833B2
(ja)
|
2015-10-22 |
2021-08-18 |
モデルナティーエックス, インコーポレイテッド |
ヒトサイトメガロウイルスワクチン
|
EP3364950A4
(de)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
Impfstoffe gegen tropenkrankheiten
|
US10138298B2
(en)
|
2015-10-23 |
2018-11-27 |
The Regents Of The University Of California |
Anti-IL-2 antibodies and compositions and uses thereof
|
WO2017075037A1
(en)
|
2015-10-27 |
2017-05-04 |
Scholar Rock, Inc. |
Primed growth factors and uses thereof
|
CA3002676A1
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
CN106699889A
(zh)
|
2015-11-18 |
2017-05-24 |
礼进生物医药科技(上海)有限公司 |
抗pd-1抗体及其治疗用途
|
ES2913626T3
(es)
|
2015-12-22 |
2022-06-03 |
Modernatx Inc |
Compuestos y composiciones para la administración intracelular de agentes
|
BR112018013407A2
(pt)
|
2015-12-30 |
2018-12-18 |
Kodiak Sciences Inc |
anticorpos e conjugados dos mesmos
|
PL3405212T3
(pl)
|
2016-01-19 |
2020-11-16 |
Pfizer Inc. |
Szczepionki przeciwnowotworowe
|
TW201936640A
(zh)
|
2016-01-21 |
2019-09-16 |
美商輝瑞股份有限公司 |
對表皮生長因子受體變異體iii具特異性之抗體類及彼等之用途
|
US20190038720A1
(en)
|
2016-02-03 |
2019-02-07 |
President And Fellows Of Harvard College |
Methods of treating inflammatory bowel disease and parasite infection
|
CA3014774A1
(en)
|
2016-02-17 |
2017-08-24 |
Children's Medical Center Corporation |
Ffa1 (gpr40) as a therapeutic target for neural angiogenesis diseases or disorders
|
US20210309965A1
(en)
|
2016-03-21 |
2021-10-07 |
Dana-Farber Cancer Institute, Inc. |
T-cell exhaustion state-specific gene expression regulators and uses thereof
|
US11020160B2
(en)
|
2016-03-21 |
2021-06-01 |
Warsaw Orthopedic, Inc. |
Surgical injection system and method
|
US10927383B2
(en)
|
2016-06-30 |
2021-02-23 |
Ethris Gmbh |
Cas9 mRNAs
|
AU2017332721B2
(en)
|
2016-09-20 |
2023-11-09 |
Sara BUHRLAGE |
Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators
|
JP6951429B2
(ja)
|
2016-09-20 |
2021-10-20 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーBoehringer Ingelheim Vetmedica GmbH |
新規のブタインフルエンザワクチン
|
CN109790550B
(zh)
|
2016-09-20 |
2024-02-09 |
勃林格殷格翰动物保健有限公司 |
新颖的启动子
|
CN109715219B
(zh)
|
2016-09-20 |
2024-03-01 |
勃林格殷格翰动物保健有限公司 |
犬腺病毒载体
|
EP3515481A1
(de)
|
2016-09-20 |
2019-07-31 |
Boehringer Ingelheim Vetmedica GmbH |
Neue ehv-einsetzstelle orf70
|
CA3041307A1
(en)
|
2016-10-21 |
2018-04-26 |
Giuseppe Ciaramella |
Human cytomegalovirus vaccine
|
UA127859C2
(uk)
|
2016-11-03 |
2024-01-31 |
Бьорінгер Інгельхайм Ветмедіка Гмбх |
Вакцина проти свинячого парвовірусу
|
EP3534939B1
(de)
|
2016-11-03 |
2023-02-22 |
Boehringer Ingelheim Vetmedica GmbH |
Impfstoff gegen das schweineparvovirus und das reproduktions- und atemwegsyndrom verursachende schweinevirus sowie herstellungsverfahren davon
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
EP3538146A4
(de)
|
2016-11-11 |
2020-07-15 |
ModernaTX, Inc. |
Influenza-impfstoff
|
JP2020500020A
(ja)
|
2016-11-14 |
2020-01-09 |
ノバルティス アーゲー |
融合誘導性タンパク質minionに関連する組成物、方法、および治療上の使用
|
US11103578B2
(en)
|
2016-12-08 |
2021-08-31 |
Modernatx, Inc. |
Respiratory virus nucleic acid vaccines
|
KR20190110605A
(ko)
|
2017-01-30 |
2019-09-30 |
베링거 인겔하임 애니멀 헬스 유에스에이 인크. |
돼지 코로나바이러스 백신
|
EP3582790A4
(de)
|
2017-02-16 |
2020-11-25 |
ModernaTX, Inc. |
Hochwirksame immunogene zusammensetzungen
|
AU2018224326B2
(en)
|
2017-02-27 |
2024-01-04 |
Translate Bio, Inc. |
Novel codon-optimized CFTR mRNA
|
EP3589657A1
(de)
|
2017-03-03 |
2020-01-08 |
Rinat Neuroscience Corp. |
Anti-gitr-antikörper und verfahren zur verwendung davon
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
WO2018170256A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
US11045540B2
(en)
|
2017-03-15 |
2021-06-29 |
Modernatx, Inc. |
Varicella zoster virus (VZV) vaccine
|
ES2940259T3
(es)
|
2017-03-15 |
2023-05-04 |
Modernatx Inc |
Compuesto y composiciones para la administración intracelular de agentes terapéuticos
|
WO2018170260A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
US20200056190A1
(en)
|
2017-03-16 |
2020-02-20 |
Pfizer Inc. |
Tyrosine prototrophy
|
US20200030432A1
(en)
|
2017-03-17 |
2020-01-30 |
Modernatx, Inc. |
Zoonotic disease rna vaccines
|
EP3610010A4
(de)
|
2017-04-14 |
2021-02-24 |
Kodiak Sciences Inc. |
Komplementfaktor-d-antagonisten-antikörper und konjugate davon
|
US11173190B2
(en)
|
2017-05-16 |
2021-11-16 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
|
MX2019014465A
(es)
|
2017-06-02 |
2020-01-23 |
Pfizer |
Anticuerpos especificos para flt3 y sus usos.
|
EP3634496A4
(de)
|
2017-06-06 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur sensibilisierung von krebszellen gegen t-zell-vermittelte abtötung mittels modulierung von molekularen signalwegen
|
AU2018284077B2
(en)
|
2017-06-13 |
2021-09-23 |
Bostongene Corporation |
Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
US11179457B2
(en)
|
2017-07-12 |
2021-11-23 |
Boehringer Ingelheim Animal Health USA Inc. |
Senecavirus a immunogenic compositions and methods thereof
|
CN110997002A
(zh)
|
2017-07-13 |
2020-04-10 |
麻省理工学院 |
靶向hdac2-sp3复合体以增强突触功能
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
US11744801B2
(en)
|
2017-08-31 |
2023-09-05 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
EP3681514A4
(de)
|
2017-09-14 |
2021-07-14 |
ModernaTX, Inc. |
Rna-vakzine gegen zika-virus
|
AR113124A1
(es)
|
2017-09-23 |
2020-01-29 |
Boehringer Ingelheim Vetmedica Gmbh |
Sistema de expresión de paramyxoviridae
|
WO2019070161A2
(en)
|
2017-10-04 |
2019-04-11 |
Opko Pharmaceuticals, Llc |
ARTICLES AND METHODS FOR PERSONALIZED THERAPY OF CANCER
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
US11911453B2
(en)
|
2018-01-29 |
2024-02-27 |
Modernatx, Inc. |
RSV RNA vaccines
|
JP2021511811A
(ja)
|
2018-02-01 |
2021-05-13 |
ファイザー・インク |
Cd70に特異的な抗体およびその使用
|
WO2019152742A1
(en)
|
2018-02-01 |
2019-08-08 |
Pfizer Inc. |
Chimeric antigen receptors targeting cd70
|
CN111712575A
(zh)
|
2018-02-23 |
2020-09-25 |
勃林格殷格翰动物保健有限公司 |
表达外源猫副粘病毒基因的重组病毒载体系统及由其制备的疫苗
|
WO2019166946A1
(en)
|
2018-02-28 |
2019-09-06 |
Pfizer Inc. |
Il-15 variants and uses thereof
|
EA202092164A1
(ru)
|
2018-03-19 |
2021-02-10 |
Бёрингер Ингельхайм Ветмедика Гмбх |
Новый ehv с инактивированным ul18 и/или ul8
|
AU2019239552A1
(en)
|
2018-03-19 |
2020-09-10 |
Boehringer Ingelheim Vetmedica Gmbh |
EHV insertion site UL43
|
KR20200135505A
(ko)
|
2018-03-26 |
2020-12-02 |
베링거 인겔하임 애니멀 헬스 유에스에이 인크. |
면역원성 조성물의 제조방법
|
TWI816396B
(zh)
|
2018-05-23 |
2023-09-21 |
美商輝瑞大藥廠 |
特異性針對gucy2c之抗體及其用途
|
MX2020012539A
(es)
|
2018-05-23 |
2021-02-16 |
Pfizer |
Anticuerpos especificos para cd3 y sus usos.
|
GB201811382D0
(en)
|
2018-07-11 |
2018-08-29 |
Taylor John Hermon |
Vaccine
|
WO2020053808A1
(en)
|
2018-09-12 |
2020-03-19 |
Georg Dewald |
Method of diagnosing vasoregulatory disorders
|
EP3852800A1
(de)
|
2018-09-20 |
2021-07-28 |
Boehringer Ingelheim Vetmedica GmbH |
Intranasaler vektorimpfstoff gegen epidemische virusdiarrhoe
|
JP7284822B2
(ja)
|
2018-09-20 |
2023-05-31 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
改変pedvスパイクタンパク質
|
SG11202107606VA
(en)
|
2019-01-15 |
2021-08-30 |
Inst Nat Sante Rech Med |
Mutated interleukin-34 (il-34) polypeptides and uses thereof in therapy
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
IT201900007060A1
(it)
|
2019-05-21 |
2020-11-21 |
St Superiore Di Sanita |
Cellule tumorali ingegnerizzate e loro usi
|
WO2021028726A2
(en)
|
2019-07-03 |
2021-02-18 |
Bostongene Corporation |
Systems and methods for sample preparation, sample sequencing, and sequencing data bias correction and quality control
|
IT201900012540A1
(it)
|
2019-07-22 |
2021-01-22 |
Humanitas Mirasole Spa |
Inibitori di CHI3L1 e loro usi
|
CN114728887A
(zh)
|
2019-09-19 |
2022-07-08 |
摩登纳特斯有限公司 |
用于治疗剂的细胞内递送的支链尾端脂质化合物和组合物
|
US20240050529A1
(en)
|
2019-10-07 |
2024-02-15 |
University Of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
EP4041312A4
(de)
|
2019-10-10 |
2023-12-20 |
Kodiak Sciences Inc. |
Verfahren zur behandlung einer augenstörung
|
WO2021072244A1
(en)
|
2019-10-11 |
2021-04-15 |
Beth Israel Deaconess Medical Center, Inc. |
Anti-tn antibodies and uses thereof
|
EP4093426A1
(de)
|
2020-01-24 |
2022-11-30 |
University of Virginia Patent Foundation |
Modulation von lymphgefässen bei neurologischen erkrankungen
|
EP4100420A1
(de)
|
2020-02-06 |
2022-12-14 |
Boehringer Ingelheim Vetmedica GmbH |
Polypeptide zur detektion von anti-rhabdovirus-antikörpern
|
WO2021205325A1
(en)
|
2020-04-08 |
2021-10-14 |
Pfizer Inc. |
Anti-gucy2c antibodies and uses thereof
|
EP4136219A1
(de)
|
2020-04-16 |
2023-02-22 |
Par'Immune SAS |
28 gst proteine aus schistosoma kda zur behandlung von vaskulitis
|
WO2021224850A1
(en)
|
2020-05-06 |
2021-11-11 |
Crispr Therapeutics Ag |
Mask peptides and masked anti-ptk7 antibodies comprising such
|
EP4157264A1
(de)
|
2020-05-27 |
2023-04-05 |
The Regents of the University of California |
Zusammensetzungen und verfahren zur transdifferenzierung von zellen
|
CA3189590A1
(en)
|
2020-07-17 |
2022-01-20 |
Pfizer Inc. |
Therapeutic antibodies and their uses
|
JP2022025558A
(ja)
|
2020-07-29 |
2022-02-10 |
学校法人帝京大学 |
miR-96-5pインヒビターとそれを含有する医薬組成物
|
CA3190227A1
(en)
|
2020-07-30 |
2022-02-03 |
Pfizer Inc. |
Cells having gene duplications and uses thereof
|
US11406703B2
(en)
|
2020-08-25 |
2022-08-09 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
CN116438195A
(zh)
|
2020-10-05 |
2023-07-14 |
勃林格殷格翰动物保健有限公司 |
用于针对轮状病毒疫苗接种的融合蛋白质
|
CN116438202A
(zh)
|
2020-10-05 |
2023-07-14 |
勃林格殷格翰动物保健美国有限公司 |
包含圆环病毒科衣壳蛋白的融合蛋白及其构成的嵌合病毒样颗粒
|
WO2022086852A2
(en)
|
2020-10-19 |
2022-04-28 |
Dana-Farber Cancer Institute, Inc. |
Germline biomarkers of clinical response and benefit to immune checkpoint inhibitor therapy
|
WO2022104104A2
(en)
|
2020-11-13 |
2022-05-19 |
Dana-Farber Cancer Institute, Inc. |
Personalized fusion cell vaccines
|
WO2022120256A2
(en)
|
2020-12-04 |
2022-06-09 |
Bostongene Corporation |
Hierarchical machine learning techniques for identifying molecular categories from expression data
|
WO2022159793A2
(en)
|
2021-01-25 |
2022-07-28 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for identifying neuroendocrine prostate cancer
|
US20220372580A1
(en)
|
2021-04-29 |
2022-11-24 |
Bostongene Corporation |
Machine learning techniques for estimating tumor cell expression in complex tumor tissue
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
CA3227875A1
(en)
|
2021-08-02 |
2023-02-09 |
Pfizer Inc. |
Improved expression vectors and uses thereof
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
US20230245479A1
(en)
|
2022-01-31 |
2023-08-03 |
Bostongene Corporation |
Machine learning techniques for cytometry
|
WO2023148598A1
(en)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Cysteine prototrophy
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
US20240050555A1
(en)
|
2022-04-05 |
2024-02-15 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for vaccination against rotavirus
|
US20240029884A1
(en)
|
2022-07-15 |
2024-01-25 |
Bostongene Corporation |
Techniques for detecting homologous recombination deficiency (hrd)
|